New PARP inhibitor trial hopes to shrink Hard-to-Treat cancers
Disease control
Recruiting now
This study tests a new drug called ACE-86225106 in people with advanced solid tumors (like ovarian, breast, or prostate cancer) that have BRCA gene mutations. The goal is to see if the drug is safe and can shrink tumors. About 298 adults will take the drug, and researchers will m…
Phase: PHASE1, PHASE2 • Sponsor: Acerand Therapeutics (Shanghai) Limited • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC